Latest / AudioScholar Rheumatology Weekly
Holding DMARDs post-booster: no antibody gain, more flares
Editor's Pick: Temporary Cessation of DMARD Therapy and COVID-19 Supplemental Dose Vaccine Immunogenicity in Patients With Inflammatory Arthritis: The COVER Randomized Clinical Trial (JAMA Internal Medicine, 2026)
This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice.
Welcome to This Week in Rheumatology. This week we're covering 10 notable papers spanning when and how to step back from targeted therapy in inflammatory arthritis, the long shadow of glucocorticoids in lupus and polymyalgia, and the emerging…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.